$12M capital infusion pumps Prairie Village-based Artio Medical to $46M in funding
April 29, 2021 | Startland News Staff
A Johnson County medical device company announced Thursday the closing of an additional $12 million tranche of Series A financing — advancing the startup’s tech toward clinical study and commercialization with the backing of a leading Kansas City real estate developer.
“We are thrilled to close this round of financing with strong support from existing investors who share our mission to provide better patient outcomes,” said Dr. F. Nicholas Franano, president and CEO of Artio. “The Artio team is focused on the road ahead as we advance multiple development programs and prepare for commercialization of our first product.”
The funding brings Artio’s total capital raised to $46 million, Franano said.
Click here to see why Artio Medical, formerly also known as Metactive, was named one of Startland News’ Kansas City Startups to Watch in 2019.
Led by existing investors Sarah Hagedorn and Nathaniel Hagedorn — founder and CEO of Northpoint Development — the deal announced Thursday will be used to accelerate the development of Artio’s peripheral vascular product pipeline, which is highly complementary with significant overlap in call points and procedures, the company said.
The Amplifi Vein Dilation System, which aims to prepare hemodialysis patients for successful vascular access site creation, has shown promising results in initial clinical testing, Artio said in a press release. And the Solus Gold Embolization Device comprises a low-profile, flexible catheter assembly and a non-porous, gold balloon-like implant and is designed for precise placement and immediate vessel occlusion. The device has shown exceptional performance in preclinical testing, the company said.
“Nick has built a broad, diverse portfolio of highly innovative products at Artio and is assembling a world-class team to develop and commercialize them,” said Nathaniel Hagedorn. “We were pleased to have the opportunity to lead this round of financing and to invest additional capital to move the company and its mission forward.”
Just over a year ago, Artio announced its rebranding from “Metactive” and a fresh $8.8 million round to help boost its best-in-class products for the peripheral vascular and neurovascular markets.
Click here to learn more about Artio Medical.
Featured Business
2021 Startups to Watch
stats here
Related Posts on Startland News
Balancing disruption: Proposal might ban big parts of KC from short-term rentals
Feb. 22 update: After a robust, 40-minute conversation Thursday, the full Kansas City Council voted 7-4 to pass a proposed ordinance that would prohibit short-term rentals in residential neighborhoods zoned as R-7.5 and R-10. Voting yes: council members Scott Wagner, Heather Hall, Dan Fowler, Lee Barnes, Jr., Alissia Canady, Scott Taylor and Kevin McManus. Voting…
MADE’s Heartbreak Kids splits design silence on tension with Charlie Hustle
Streetwear is about making a statement, Vu Radley said, and the Heartbreak Kids collection says more than words alone could express. “It’s an attitude. Pushing out statements without censoring yourself,” said Radley, co-founder and creative director for MADE Urban Apparel. “We say it how it is in our designs.” For the Heartbreak Kids capsule, which…
Want a globally competitive KC? Look beyond smart city ‘bling,’ Digi.City founder says
The U.S. has a lot of catching up to do, said Chelsea Collier, founder of Digi.City. It’s not quite doomsday, but Collier wanted to express a sense of urgency, she said Friday during a Smart Metro Summit at Plexpod Westport Commons. Cities need to get smart — fast — or the United States will continue to…
Techstars’ Lesa Mitchell: Non-sexy sectors are ripe for disruption
Editor’s note: The opinions expressed in this commentary are the author’s alone. In the process of looking for a new crop of companies to invest in on behalf of Techstars Kansas City, I thought I should highlight the type of companies I think are undervalued and critical to our economy. In 2017 we invested in…